{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:23:42Z","timestamp":1791350622627,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA098804"],"award-info":[{"award-number":["R01-CA098804"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Staten Island University Hospital Research Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bbrc.2014.03.100","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T14:45:33Z","timestamp":1396104333000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sensitization of mesothelioma cells to platinum-based chemotherapy by GST\u03c0 knockdown"],"prefix":"10.1016","volume":"447","author":[{"given":"Jianli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Solomides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Simpkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.03.100_b0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2014.03.100_b0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"van Meerbeeck","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/CCO.0b013e328324bc30","article-title":"Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?","volume":"21","author":"Stahel","year":"2009","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0025","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1200\/JCO.2006.08.0267","article-title":"Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage","volume":"24","author":"Aelony","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/cncr.22366","article-title":"Efficacy and safety of first-or second-line irinotecan, cisplatin, and mitomycin in mesothelioma","volume":"109","author":"Fennel","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jjco\/hyi127","article-title":"Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma","volume":"35","author":"Maruyama","year":"2005","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11864-008-0071-3","article-title":"Systemic treatments for mesothelioma: standard and novel","volume":"9","author":"Kindler","year":"2008","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6673-3-34","article-title":"Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study","volume":"3","author":"Xanthopoulos","year":"2008","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1993.321","article-title":"Glutathione-S-transferase expression in benign and malignant ovarian tumors","volume":"88","author":"Green","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<521::AID-CNCR14>3.0.CO;2-5","article-title":"Glutathione-S-transferase \u03c0 expression and glutathione concentration in ovarian carcinoma before and after chemotherapy","volume":"79","author":"Cheng","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0060","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00428-005-1228-0","article-title":"Augmented expression of metallothionein and glutathione-S-transferese \u03c0 as unfavorable prognostic factors in cisplatin-treated ovarian cancer patients","volume":"447","author":"Surowiak","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbrc.2014.03.100_b0065","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/bjc.1992.388","article-title":"Glutathione-S-transferase activity and isoenzyme composition in benign ovarian tumors, untreated malignant ovarian tumors and malignant tumors after platinum\/cyclophosphamide chemotherapy","volume":"66","author":"van der Zee","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/bjc.1996.384","article-title":"The relationship between tumor glutathione concentration, glutathione-S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients","volume":"74","author":"Ghazal-Aswad","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1525-1438.2003.13381.x","article-title":"Multivariate analysis for prognostic significance of histologic subtype. GST\u03c0, MDR-1 and p53 in stages II-IV ovarian cancer","volume":"13","author":"Ikeda","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0080","first-page":"8097","article-title":"Glutathione-S-transferase \u03c0 amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors","volume":"63","author":"Cullen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0085","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/1097-0142(19940815)74:4<1230::AID-CNCR2820740409>3.0.CO;2-0","article-title":"Expression of glutathione-S-transferase pi and sensitivity in human gastric cancer cells to cisplatin","volume":"74","author":"Okuyama","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00685078","article-title":"Expression of glutathione-S-transferase \u03b1 and \u03c0 in gastric cancer: a correlation with cisplatin resistance","volume":"34","author":"Kodera","year":"1994","journal-title":"Cancer Chem. Pharm."},{"key":"10.1016\/j.bbrc.2014.03.100_b0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<416::AID-CNCR6>3.0.CO;2-H","article-title":"Immunohistochemical expression of glutathione-S-transferase \u03c0 can predict chemotherapy response in patients with non-small cell lung carcinoma","volume":"78","author":"Bai","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2014.03.100_b0100","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/0008-5472.CAN-07-5840","article-title":"Overcoming glutathione-S-transferase pi-related cisplatin resistance in osteosarcoma","volume":"68","author":"Pasello","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/cas.12061","article-title":"Glutathione S-transferease P1-1 as a target for mesothelioma treatment","volume":"104","author":"De Luca","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2014.03.100_b0110","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1158\/0008-5472.CAN-04-3903","article-title":"Proapoptotic activity of new glutathione S-transferase inhibitors","volume":"65","author":"Turella","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0115","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/0008-5472.CAN-07-5840","article-title":"Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma","volume":"68","author":"Pasello","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0120","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood-2003-12-4299","article-title":"Glutathione S-transferase \u03c0 inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism","volume":"105","author":"Zhou","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.03.100_b0125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/pro.609","article-title":"GST pi modulates JNK activity through a direct interaction with JNK substrate, ATF2","volume":"20","author":"Thevenin","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrc.2014.03.100_b0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002800050412","article-title":"Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells","volume":"37","author":"Parekh","year":"1996","journal-title":"Cancer Chem. Pharm."},{"key":"10.1016\/j.bbrc.2014.03.100_b0135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00280-007-0638-x","article-title":"C-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells","volume":"62","author":"Takada","year":"2008","journal-title":"Cancer Chem. Pharm."},{"key":"10.1016\/j.bbrc.2014.03.100_b0140","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","article-title":"Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation","volume":"249","author":"Habig","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.03.100_b0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","article-title":"DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination","volume":"127","author":"Korch","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0150","doi-asserted-by":"crossref","first-page":"H1289","DOI":"10.1152\/ajpheart.00811.2003","article-title":"Hypothermia augments reactive oxygen species in the guinea pig isolated heart","volume":"286","author":"Camara","year":"2004","journal-title":"Am. J. Physiol. (Heart Circ. Physiol.)"},{"key":"10.1016\/j.bbrc.2014.03.100_b0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.radphyschem.2004.06.011","article-title":"Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 2\u2032,7\u2032-dichlorofluorescein diacetate assay","volume":"72","author":"Loetchutinat","year":"2005","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.bbrc.2014.03.100_b0160","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"Townsend","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.03.100_b0165","first-page":"3577","article-title":"Transfection of glutathione-S-transferase (GST)-\u03c0 antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan and etoposide","volume":"56","author":"Ban","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0170","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2014.03.100_b0175","doi-asserted-by":"crossref","first-page":"18638","DOI":"10.1073\/pnas.1303958110","article-title":"Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug","volume":"110","author":"Xu","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2014.03.100_b0180","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10495-007-0082-8","article-title":"Apoptosis by cisplatin requires p53 mediated p38\u03b1 MAPK activation through ROS generation","volume":"12","author":"Bragado","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2014.03.100_b0185","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jcp.22397","article-title":"Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells","volume":"226","author":"Eguchi","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00277-006-0139-8","article-title":"Role of GSTP1-1 in mediating the effect of As2O3 in the acute promyelocytic leukemia cell line NB4","volume":"85","author":"Bernadini","year":"2006","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbrc.2014.03.100_b0195","first-page":"8103","article-title":"Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival","volume":"63","author":"Berger","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0200","first-page":"183","article-title":"Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas","volume":"29","author":"Knippen","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0205","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/hed.21648","article-title":"Activating transcription factor-2 (ATF2) in survival mechanisms in head and neck carcinoma cells","volume":"33","author":"Duffey","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.bbrc.2014.03.100_b0210","first-page":"331","article-title":"Activating transcription factor 2-derived peptides alter resistance of humor tumor cell lines to ultraviolet irradiation and chemical treatment","volume":"7","author":"Bhoumik","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2014.03.100_b0215","doi-asserted-by":"crossref","first-page":"20562","DOI":"10.1074\/jbc.M210992200","article-title":"The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair","volume":"278","author":"Hayakawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.03.100_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jcs.095000","article-title":"ATF2-at the crossroads of nuclear and cytosolic functions","volume":"125","author":"Lau","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2014.03.100_b0225","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1021\/bi300559m","article-title":"New insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1","volume":"51","author":"De Luca","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2014.03.100_b0230","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2014.03.100_b0235","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/onc.2009.327","article-title":"Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy","volume":"29","author":"Yang","year":"2010","journal-title":"Oncogene"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1400552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1400552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:25:36Z","timestamp":1648718736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1400552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0006291X1400552X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.100","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitization of mesothelioma cells to platinum-based chemotherapy by GST\u03c0 knockdown","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}